Search Results - "Petkovic, Vibor"

Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43 by Miletta, Maria Consolata, Petkovic, Vibor, Eblé, Andrée, Ammann, Roland A, Flück, Christa E, Mullis, Primus-E

“…Butyrate is a short-chain fatty acid (SCFA) closely related to the ketone body ß-hydroxybutyrate (BHB), which is considered to be the major energy substrate…”
Get full text

Effect of Zinc Binding Residues in Growth Hormone (GH) and Altered Intracellular Zinc Content on Regulated GH Secretion by Petkovic, Vibor, Miletta, Maria Consolata, Eblé, Andrée, Iliev, Daniel I, Binder, Gerhard, Flück, Christa E, Mullis, Primus E

“…Endocrine cells store hormones in concentrated forms (aggregates) in dense-core secretory granules that are released upon appropriate stimulation. Zn2+ binding…”
Get full text

Transient Neonatal Zinc Deficiency Caused by a Heterozygous G87R Mutation in the Zinc Transporter ZnT-2 (SLC30A2) Gene in the Mother Highlighting the Importance of Zn^(2+) for Normal Growth and Development by Maria Consolata Miletta, Andreas Bieri, Kristin Kernland, Martin H. Schöni, Vibor Petkovic, Christa E. Flück, Andrée Eblé, Primus E.Mullis

“…Suboptimal dietary zinc (Zn(2+)) intake is increasingly appreciated as an important public health issue. Zn(2+) is an essential mineral, and infants are…”
Get full text

A rich chemokine environment strongly enhances leukocyte migration and activities by Paoletti, Samantha, Petkovic, Vibor, Sebastiani, Silvia, Danelon, M.Gabriela, Uguccioni, Mariagrazia, Gerber, Basil O.

“…The migration of leukocytes in immune surveillance and inflammation is largely determined by their response to chemokines. While the chemokine specificities…”
Get full text

Transient Neonatal Zinc Deficiency Caused by a Heterozygous G87R Mutation in the Zinc Transporter ZnT-2 (SLC30A2) Gene in the Mother Highlighting the Importance of Zn2+ for Normal Growth and Development by Mullis, Primus E., Flück, Christa E., Petkovic, Vibor, Eblé, Andrée, Schöni, Martin H., Kernland, Kristin, Miletta, Maria Consolata, Bieri, Andreas

“…Suboptimal dietary zinc (Zn2+) intake is increasingly appreciated as an important public health issue. Zn2+ is an essential mineral, and infants are…”
Get full text

Alteration of ZnT5-mediated zinc import into the early secretory pathway affects the secretion of growth hormone from rat pituitary cells by Petkovic, Vibor, Miletta, Maria Consolata, Eblé, Andrée, Flück, Christa E, Mullis, Primus-E

“…Aggregation of growth hormone (GH) required for its proper storage in granules is facilitated by zinc (Zn(2+)) transported by specific zinc transporters in and…”
Get more information

Growth Hormone (GH)-Releasing Hormone Increases the Expression of the Dominant-Negative GH Isoform in Cases of Isolated GH Deficiency due to GH Splice-Site Mutations by Petkovic, Vibor, Godi, Michela, Lochmatter, Didier, Eblé, Andrée, Flück, Christa E, Robinson, Iain C, Mullis, Primus E

“…An autosomal dominant form of isolated GH deficiency (IGHD II) can result from heterozygous splice site mutations that weaken recognition of exon 3 leading to…”
Get full text

Isolated GH Deficiency Type II: Knockdown of the Harmful Δ3GH Recovers wt-GH Secretion in Rat Tumor Pituitary Cells by Lochmatter, Didier, Strom, Molly, Eblé, André, Petkovic, Vibor, Flück, Christa E, Bidlingmaier, Martin, Robinson, Iain C, Mullis, Primus E

“…Isolated GH deficiency type II (IGHD II) is the autosomal dominant form of GHD. In the majority of the cases, this disorder is due to specific GH-1 gene…”
Get full text

I-TAC/CXCL11 is a natural antagonist for CCR5 by Petkovic, Vibor, Moghini, Christian, Paoletti, Samantha, Uguccioni, Mariagrazia, Gerber, Basil

“…The selective CXC chemokine receptor 3 (CXCR3) agonists, monokine induced by interferon‐γ (IFN‐ γ)/CXC chemokine ligand 9 (CXCL9), IFN‐inducible protein…”
Get full text

Isolated growth hormone deficiency type 2: from gene to therapy by Miletta, Maria Consolata, Lochmatter, Didier, Pektovic, Vibor, Mullis, Primus-E

“…Isolated growth hormone deficiency type-2 (IGHD-2), the autosomal-dominant form of GH deficiency, is mainly caused by specific splicing mutations in the human…”
Get more information

Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5 by Petkovic, Vibor, Moghini, Christian, Paoletti, Samantha, Uguccioni, Mariagrazia, Gerber, Basil

“…Eotaxin-3 (CCL26), like eotaxin (CCL11) and eotaxin-2 (CCL24), has long been considered a specific agonist for CC chemokine receptor 3 (CCR3), attracting and…”
Get full text

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression by Mueller, Beatrice U., Pabst, Thomas, Fos, José, Petkovic, Vibor, Fey, Martin F., Asou, Norio, Buergi, Ulrich, Tenen, Daniel G.

“…Tightly regulated expression of the transcription factor PU.1 is crucial for normal hematopoiesis. PU.1 knockdown mice develop acute myeloid leukemia (AML),…”
Get full text

Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing by Miletta, Maria Consolata, Petkovic, Vibor, Eblé, Andrée, Flück, Christa E, Mullis, Primus-E

“…Isolated GH deficiency (IGHD) type II, the autosomal dominant form of GHD, is mainly caused by mutations that affect splicing of GH-1. When misspliced RNA is…”
Get full text

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis by Fos, José, Pabst, Thomas, Petkovic, Vibor, Ratschiller, Daniel, Mueller, Beatrice U.

“…CCAAT/enhancer binding protein-α (CEBPA) mutations in acute myeloid leukemia (AML) patients with a normal karyotype (NK) confer favorable prognosis, whereas…”
Get full text

Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes by Kuscher, Katrin, Danelon, Gabriela, Paoletti, Samantha, Stefano, Luisa, Schiraldi, Milena, Petkovic, Vibor, Locati, Massimo, Gerber, Basil O, Uguccioni, Mariagrazia

“…The migration of monocytes to sites of inflammation is largely determined by their response to chemokines. Although the chemokine specificities and expression…”
Get full text

Influence of Growth Hormone (GH) Receptor Deletion of Exon 3 and Full-Length Isoforms on GH Response and Final Height in Patients with Severe GH Deficiency by Räz, Barbara, Janner, Marco, Petkovic, Vibor, Lochmatter, Didier, Eblé, Andrée, Dattani, Mehul T., Hindmarsh, Peter C., Flück, Christa E., Mullis, Primus E.

“…Context: A polymorphism of the GH receptor (GHR) gene resulting in genomic deletion of exon 3 (GHR-d3) has been associated with responsiveness to GH therapy…”
Get full text

Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role by Petkovic, Vibor, Moghini, Christian, Paoletti, Samantha, Uguccioni, Mariagrazia, Gerber, Basil

“…Eotaxin-3 (CCL26), like eotaxin (CCL11) and eotaxin-2 (CCL24), has long been considered a specific agonist for CC chemokine receptor 3 (CCR3), attracting and…”
Get full text

The role of zinc dynamics in growth hormone secretion by Miletta, Maria Consolata, Schöni, Martin H, Kernland, Kristin, Mullis, Primus E, Petkovic, Vibor

“…Human growth hormone (GH) causes a variety of physiological and metabolic effects in humans and plays a pivotal role in postnatal growth. In somatotroph cells…”
Get more information

Heterozygous GHR gene mutation in a child with idiopathic short stature by Pagani, Sara, Petkovic, Vibor, Messini, Beatrice, Meazza, Cristina, Bozzola, Elena, Mullis, Primus-E, Bozzola, Mauro

“…Several monogenic defects have been reported to be associated with idiopathic short stature. Focusing on growth hormone receptor (GHR)-gene alterations, the…”
Get more information

Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action by Petkovic, Vibor, Godi, Michela, Pandey, Amit V, Lochmatter, Didier, Buchanan, Charles R, Dattani, Mehul T, Eblé, Andrée, Flück, Christa E, Mullis, Primus E

“…Context and Objective: Main features of the autosomal dominant form of GH deficiency (IGHD II) include markedly reduced secretion of GH combined with low…”
Get full text